A former IDF medic now working as Moderna’s chief scientist hailed the US drug company’s progress in the race for a Covid-19 vaccine.
Dr Tal Zaks spoke to BBC News on Monday after Moderna announced that early data appears to show a 94.5 percent effectiveness rate against Covid-19.
The company, like competitor Pfizer Inc, which recently announced similar results, is expected to apply for emergency-use authorisation from the Food and Drug Administration.
"The overall effectiveness has been remarkable,” Dr Zaks told the broadcaster. “It's a great day.”
Congratulations to Moderna on today’s promising vaccine test results and to Chief Medical Officer, Dr. Tal Zaks, who received his MD and PhD from Ben Gurion University in the Negev. Another great example of Israelis and Americans working together to make the world a better place!
— David M. Friedman (@USAmbIsrael) November 16, 2020
Dr Zaks, who studied at Ben Gurion University of the Negev, now lives in Massachusetts in the US.
He previously spoke about the “first-rate” training he received in Israel and referred to his experience in the IDF, according to Jewish-American news website The Algemeiner.
